Gyrus receives milestone payment from Johnson & Johnson:
This article was originally published in Clinica
Executive Summary
UK company Gyrus has been issued a US patent for its PlasmaKinetic technology, triggering a $1.5 million milestone payment from Johnson & Johnson. Marlow, Cardiff-based Gyrus's radio-frequency energy delivery technology is incorporated into the company's three commercialised products: the VAPR system for arthroscopic surgery; the VersaPoint system for hysteroscopic surgery; and the Gyrus endourology system for minimally-invasive treatment of the prostate.